Table 2.
All patients | Early stage (stages 1–2) | Advanced stage (stages 3–4) | Unknown stage | |
---|---|---|---|---|
Subject # | 49 | 24 | 23 | 2 |
CTC detection (≥1 CTC/2 mL) | 42 (86%) | 21 (88%) | 20 (87%) | 1 (50%) |
PD-L1(+) CTC | 28 (67%) | 12 (57%) | 16 (80%) | 0 |
PD-L1(−) CTC | 14 (33%) | 9 (43%) | 4 (20%) | 1 (100%) |